(Q38773904)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Tiziana Bonaldi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Alberto Bardelli

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Giuseppe Penna

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Maria Rescigno

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Alessandro Cuomo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Ilaria Spadoni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Elena Magni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Alessio Silvola

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Alexia Conte

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Sara Sigismund

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Paola Simona Ravenda

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Maria Giulia Zampino

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Carlotta Cancelliere

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Pier Paolo Di Fiore

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

English

0 references

publication date

2 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

624-631

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm.4078

3 April 2020

exact match

0 references

cites work

Metastatic colorectal cancer: current state and future directions

1 reference

Biologic therapies in the metastatic colorectal cancer treatment continuum--applying current evidence to clinical practice.

21 January 2018

1 reference

PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

21 January 2018

1 reference

Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study

21 January 2018

1 reference

ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics

21 January 2018

1 reference

Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy: a pooled analysis of three trials.

21 January 2018

1 reference

The secret ally: immunostimulation by anticancer drugs

21 January 2018

1 reference

Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway

21 January 2018

1 reference

Consensus guidelines for the detection of immunogenic cell death

21 January 2018

1 reference

Trial Watch: Chemotherapy with immunogenic cell death inducers.

21 January 2018

1 reference

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin

21 January 2018

1 reference

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

21 January 2018

1 reference

Stress responses from the endoplasmic reticulum in cancer

21 January 2018

1 reference

The impact of the endoplasmic reticulum protein-folding environment on cancer development

21 January 2018

1 reference

Induction of immunogenic apoptosis by blockade of epidermal growth factor receptor activation with a specific antibody.

21 January 2018

1 reference

Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studies

21 January 2018

1 reference

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

21 January 2018

1 reference

Rare Though Not Mutually Exclusive: A Report of Three Cases of Concomitant KRAS and BRAF Mutation and a Review of the Literature

21 January 2018

1 reference

Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.

21 January 2018

1 reference

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

21 January 2018

1 reference

Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials

21 January 2018

1 reference

Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis

21 January 2018

1 reference

RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells

21 January 2018

1 reference

Threshold-controlled ubiquitination of the EGFR directs receptor fate

21 January 2018

1 reference

Immunogenic death of colon cancer cells treated with oxaliplatin

21 January 2018

1 reference

In-gel digestion for mass spectrometric characterization of proteins and proteomes

21 January 2018

1 reference

Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips

21 January 2018

1 reference

A dual pressure linear ion trap Orbitrap instrument with very high sequencing speed.

21 January 2018

1 reference

Andromeda: a peptide search engine integrated into the MaxQuant environment

21 January 2018

1 reference

Target-decoy search strategy for mass spectrometry-based proteomics

21 January 2018

1 reference

MaxQuant for in-depth analysis of large SILAC datasets.

21 January 2018

1 reference

GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists

21 January 2018

1 reference

Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study

21 January 2018

1 reference

Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27135741

12 December 2020

inferred from PubMed ID database lookup

Impact of genetic profiles on the efficacy of anti-EGFR antibodies in metastatic colorectal cancer with KRAS mutation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27135741

12 December 2020

inferred from PubMed ID database lookup

BRAFMutation in Metastatic Colorectal Cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27135741

12 December 2020

inferred from PubMed ID database lookup

Moyamoya disease and moyamoya syndrome

1 reference

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NM.4078

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27135741%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference